Shiavax J. Rao/X
Oct 3, 2026, 05:32
Shiavax J. Rao: PERT 2026 Session Explores Long-Term Anticoagulation and DOAC Management
Shiavax J. Rao, Trainee Council Chair and Trainee Council Member at The PERT Consortium, Cardiology Fellow at Guthrie, shared The PERT Consortium’s post on X:
“An amazing, engaging and very insightful session at PERT 2026 covering long-term anticoagulation,
DOAC de-escalation, periprocedural guidance, addressing non-adherence, transitions of care and population-based DOAC management.”
The PERT Consortium shared a post on X:
“A huge thank you to our amazing panel of experts for an insightful discussion on anticoagulation in PE!
So many important takeaways, thought-provoking questions, and opportunities to improve clinical practice.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series